Literature DB >> 22002073

Infections in neuro-oncology.

P Gaviani1, A Silvani, E Lamperti, A Botturi, G Simonetti, I Milanesi, D Ferrari, A Salmaggi.   

Abstract

Infections represent a serious and frequent complication in neuro-oncology patients. Decreased immune defences, along with poor nutritional status are the main predisposition factors. The combined therapeutic strategies of chemotherapy and radiotherapy may favour bone marrow depression and further increase the risk of developing opportunistic infections in brain tumour patients. The spectrum of infections in neuro-oncology patients is large and includes opportunistic infections by bacteria, viruses, fungi and parasites. Importantly, a high index of suspicion for opportunistic infections in general should be maintained, especially in glioma patients receiving dose-dense schedules of temozolomide. After neurosurgical procedures, infections most commonly present as meningitis, subdural empyema, or cerebral abscess. Infections represent a frequent and possibly serious complication in general immunocompromised oncology population. It should be underlined that infections are not limited to immunocompromised patients, being also present at the early disease stages, especially due to therapeutic strategies (chemo and radiotherapy, surgical procedures). Therefore this issue deserves more attention in neuroncology setting.

Entities:  

Mesh:

Year:  2011        PMID: 22002073     DOI: 10.1007/s10072-011-0803-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya Infections.

Authors:  B Mechleb; F Khater; A Eid; G David; J P Moorman
Journal:  J Infect       Date:  2003-04       Impact factor: 6.072

Review 2.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

3.  How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.

Authors:  Wolfgang Wick; Michael Weller
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

4.  Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.

Authors:  Stuart A Grossman; Xiaobu Ye; Glenn Lesser; Andrew Sloan; Hetty Carraway; Serena Desideri; Steven Piantadosi
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

Review 5.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

6.  Pneumocystis carinii pneumonia in patients with primary brain tumors.

Authors:  J W Henson; J K Jalaj; R W Walker; D E Stover; A O Fels
Journal:  Arch Neurol       Date:  1991-04

7.  Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.

Authors:  Michael A Hughes; Michele Parisi; Stuart Grossman; Lawrence Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-01       Impact factor: 7.038

8.  Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

Authors:  Y B Su; Sejean Sohn; Susan E Krown; Philip O Livingston; Jedd D Wolchok; Carolyn Quinn; Linda Williams; Theresa Foster; Kent A Sepkowitz; Paul B Chapman
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

Review 9.  The safety of temozolomide in the treatment of malignancies.

Authors:  Van Anh Trinh; Sapna Pradyuman Patel; Wen-Jen Hwu
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

10.  Cryptococcal meningitis in patients with glioma: a report of two cases.

Authors:  Jonathan D Choi; Ciaran J Powers; James J Vredenburgh; Allan H Friedman; John H Sampson
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

View more
  3 in total

Review 1.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

2.  Subdural empyema complicated with intracranial hemorrhage in a postradiotherapy nasopharyngeal carcinoma patient: A case report and review of literature.

Authors:  Jun-Chen Chen; Dian-Hui Tan; Ze-Bin Xue; Sen-Yuan Yang; Yong Li; Run-Long Lai
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

3.  Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.

Authors:  Da-Peng Wang; Kai Kang; Qi Lin; Jian Hai
Journal:  Clin Transl Sci       Date:  2019-10-30       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.